SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-19-025382
Filing Date
2019-04-30
Accepted
2019-04-30 17:04:16
Documents
6
Period of Report
2019-06-25
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A a19-2580_1def14a.htm DEF 14A 1092572
2 GRAPHIC g25801bui001.gif GRAPHIC 171758
3 GRAPHIC g25801bui002.gif GRAPHIC 121881
4 GRAPHIC g25801bci001.gif GRAPHIC 10947
5 GRAPHIC g25801bci002.jpg GRAPHIC 1962
6 GRAPHIC g25801bci003.gif GRAPHIC 2989
  Complete submission text file 0001104659-19-025382.txt   1520469
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35619 | Film No.: 19782915
SIC: 2834 Pharmaceutical Preparations